Global ConSeptS – Consultancy
Global ConSeptS – Consultancy is an independent technical consultancy company that was established in 2008. The company specialises in aseptic processing and Quality by Design projects specific to the global bio-pharmaceutical industry. Our approach is pragmatic and to-the-point. You are our customer and we want you to get the best technical solution rather than a theoretical proposal. Although today Global ConSeptS is a one-man company, we want you to be best served. That is why we closely work together with other competent consultancy companies to provide you the best quality for your projects and assure you on-time delivery.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Emerging Markets: Your Essential Guide
White Papers and Resources | January 6, 2016 | Inizio
Using our combined knowledge and years of experience of working in these territories, our experts have produced an essential guide to help address some of the core challenges for conducting market...
Free Thinking: From promise to practice: immuno-oncology in action
White Papers and Resources | January 6, 2016 | Inizio
This white paper explores the global outlook for new immunotherapy products, referencing key opinion leaders and payers to investigate how these products are faring both clinically and financially. Immuno-oncology therapies that...
Exploring the Opportunity For Halal In Healthcare
White Papers and Resources | January 6, 2016 | Inizio
Published in Medical Marketing & Media November 2015
Case study: Opportunity Assessment for a Rare Disease Product in Emerging Markets
White Papers and Resources | January 6, 2016 | Inizio
Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets
12 Challenges Big Pharma Faces in China
White Papers and Resources | January 6, 2016 | Inizio
Published in eyeforpharma 16 November by Rachel Howard
Using mobile “diary” research to capture patient-generated insights in COPD
White Papers and Resources | January 6, 2016 | Inizio
Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients
Biosimilars in 2018: EU doctors’ perceptions of RA drug market
White Papers and Resources | January 6, 2016 | Inizio
Published in pharmaphorum October 2015 by Laurent Chanroux
Webinar: Understanding the Patient Journey in China 2015
White Papers and Resources | January 6, 2016 | Inizio
Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.
Understanding Patient Willingness to Pay
White Papers and Resources | January 6, 2016 | Inizio
Published in eyeforpharma 12 October by Rachel Howard
Doctor doctor, where are all the men?
White Papers and Resources | December 30, 2015 | Say Communications
New data show that half of men put off visiting the doctor. Why is this and what can be done to prevent it?